Heart rate lowering and outcomes in cardiovascular disease: setting the record straight

View at publisher Summarise with VIRAT
Authors: Elias A. Sanidas, H Michalopoulou, Costas Thomopoulos
Cited by: 0
References: 4

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

This commentary refers to ‘Heart rate-lowering drugs and outcomes in hypertension and/or cardiovascular disease: a meta-analysis’, by E. Sanidas et al., https://doi.org/10.1093/eurheartj/ehaf291 and the discussion piece ‘Cautions in interpreting meta-analytic estimates of HR-lowering agents’, by J. Huang and F. Fogacci. https://doi.org/10.1093/eurheartj/ehag234. We read with interest the methodological concerns raised by Huang and Fogacci1 regarding our meta-analysis of heart rate (HR)-lowering trials in individuals with hypertension and/or cardiovascular disease.2 The first issue was that the summary effect estimates were set to a standard (10 b.p.m.) HR reduction. We agree that, in general, standardizations should be avoided3; this is because the ‘real-world’ summary effect estimate is transformed to an imaginary estimate. Therefore, we did not standardize summary estimates in our primary analyses. To allow fair comparisons, because of a differential HR lowering, we standardize the averaged HR differences only in our subgroup analyses. Before this attempt, we demonstrated, through meta-regression analyses, that the extent of HR lowering was associated with the magnitude of outcome reduction on a semilogarithmic scale for most, but not all, relevant outcomes. This rationale serves as a sine qua non criterion for standardization within a predetermined range of HR differences, meaning that one may standardize only if the logarithmically reduced outcome is related to the extent of HR reduction. In our supplement,2 we debunk related concerns, especially in light of the meta-regression analyses.

Fields of Study & Subjects

Heart rate and cardiovascular health Blood Pressure and Hypertension Studies Heart Rate Variability and Autonomic Control

Publication details

Journal / source
European Heart Journal
Pages
ehag235
Publication date
31 March 2026
Language
EN